Home LiteratureArticle Details
PMID: 9854683 Published · ppublish English Journal Article

Influence of galanin and serotonin on the endocrine response to Hexarelin, a synthetic peptidyl GH-secretagogue, in normal women.

Journal of endocrinological investigation ·Vol. 21 ·No. 10 ·1998-11-00 ·Pages 673-9

Arvat E, Maccagno B, Ramunni J, Broglio F, Lanfranco F, Giordano R, Benso A, Deghenghi R, Ghigo E

Abstract

Hexarelin (HEX) is a synthetic GH-secretagogue (GHS) which acts on specific receptors either at the pituitary or the hypothalamic level to stimulate GH release both in animal and in man. Like other GHS, HEX possesses also PRL-, ACTH- and cortisol (F)-releasing activity but the mechanisms underlying these effects are even less clear. On the other hand, galanin (GAL) and serotonin play an important role in the neural control of GH, PRL and ACTH secretion both in animal and in man. In order to study the interaction between HEX and GAL and to verify whether serotoninergic mechanisms underly the endocrine effects of GHS, in 12 normal young volunteers (24-30 yr) the following tests were performed: group A (N = 5), HEX (2.0 micrograms/kg i.v. at 0 min), GAL (15.0 micrograms/kg i.v. from 0 to 60 min) and HEX + GAL; group B (N = 7), HEX alone and preceeded by cyproeptadine (CYPRO, 8 mg os at -60 min). In group A, the GH response to HEX (1204.2 +/- 312.9 micrograms*min/L) was higher (p < 0.05) than that to GAL alone (305.6 +/- 35.5 micrograms*min/L) and was not modified by GAL co-administration (1021.8 +/- 249.9 micrograms*min/L). PRL secretion was increased to the same extent by HEX and GAL (507.9 +/- 81.1 and 743.0 +/- 164.7 micrograms*min/L) which showed no interaction (603.5 +/- 75.7 micrograms*min/L). HEX elicited an increase in both ACTH and F secretion (924.5 +/- 169.7 pg*min/ml and 6131.3 +/- 616.6 micrograms*min/L) while GAL had no effect when given alone (759.5 +/- 185.5 pg*min/ml and 5350.3 +/- 755.6 micrograms*min/L) and did not modify the effect of HEX (891.3 +/- 159.2 pg*min/ml and 5877.8 +/- 554.4 micrograms*min/L). In group B, the GH response to HEX (1636.4 +/- 267.5 micrograms*min/L) was blunted by CYPRO (1164.8 +/- 212.3 micrograms*min/L) but this difference did not attained statistical significance. On the other hand, CYPRO did not modify the HEX-induced PRL (599.5 +/- 129.2 vs 638.9 +/- 131.9 micrograms*min/L), ACTH (1282.8 +/- 222.0 vs 1330.2 +/- 347.0 pg*min/ml) and F response (4738.3 +/- 355.3 vs 4580.9 +/- 857.3 micrograms*min/L). Our present data demonstrate that Hexarelin has no interaction with galanin; thus thereotically, the stimulatory effect of GHS on GH and PRL secretion could involve, at least partially, a galanin-mediated mechanism. On the other hand, our data demonstrate that serotonin does not mediate the stimulatory effect of GHS on PRL, ACTH and cortisol; the intrinsic anticholinergic property of cyproeptadine could account for the trend toward its blunting effect on the GH response to Hexarelin.

MeSH Terms
Adrenocorticotropic Hormone/metabolism Adult Cyproheptadine/pharmacology Drug Interactions Female Galanin/adverse effects,pharmacology Growth Substances/pharmacology Human Growth Hormone/metabolism Humans Kinetics Oligopeptides/adverse effects,pharmacology Prolactin/metabolism Serotonin/pharmacology
Chemicals
Growth Substances Oligopeptides hexarelin Human Growth Hormone Cyproheptadine Serotonin Galanin Adrenocorticotropic Hormone Prolactin
Authors & Affiliations
9 authors, click to expand affiliations / ORCID
Arvat E
Dipartimento di Medicina Interna, Università di Torino, Italy.
Maccagno B
Ramunni J
Broglio F
Lanfranco F
Giordano R
Benso A
Deghenghi R
Ghigo E
References (41)
41 references, click to expand
  1. Effect of human galanin on growth hormone prolactin, and antidiuretic hormone secretion in normal men.
    J Clin Endocrinol Metab. 1993 Nov;77(5):1436-8 PMID: 7521348
  2. Effects of dexamethasone and alprazolam, a benzodiazepine, on the stimulatory effect of hexarelin, a synthetic GHRP, on ACTH, cortisol and GH secretion in humans.
    Neuroendocrinology. 1998 May;67(5):310-6 PMID: 9641612
  3. On the actions of the growth hormone-releasing hexapeptide, GHRP.
    Endocrinology. 1991 Apr;128(4):2027-35 PMID: 2004615
  4. Growth hormone-releasing peptides.
    Eur J Endocrinol. 1997 May;136(5):445-60 PMID: 9186261
  5. Physiological role of galanin in the regulation of anterior pituitary function in humans.
    Am J Physiol. 1994 Jan;266(1 Pt 1):E57-61 PMID: 7508194
  6. Galanin inhibits ACTH release in vitro and can be demonstrated immunocytochemically in dispersed corticotrophs.
    Exp Cell Res. 1996 Nov 1;228(2):212-5 PMID: 8912713
  7. Morphological evidence for a galanin-opiate interaction in the rat mediobasal hypothalamus.
    J Neuroendocrinol. 1995 Aug;7(8):579-88 PMID: 8704731
  8. The growth hormone secretagogue, L-692,429, induces phosphatidylinositol hydrolysis and hormone secretion by human pituitary tumors.
    Biochem Biophys Res Commun. 1995 Mar 17;208(2):555-61 PMID: 7695607
  9. Enhanced prolactin responsiveness to galanin in patients with Cushing's disease.
    Clin Endocrinol (Oxf). 1993 Aug;39(2):213-6 PMID: 7690312
  10. Widespread transcription of the growth hormone-releasing peptide receptor gene in neuroendocrine human tumors.
    Eur J Endocrinol. 1997 Dec;137(6):715-8 PMID: 9437242
  11. Growth hormone release in man induced by galanin, a new hypothalamic peptide.
    Lancet. 1986 Jul 26;2(8500):192-5 PMID: 2425204
  12. Modulation of growth hormone-releasing activity of hexarelin in man.
    Neuroendocrinology. 1995 Jan;61(1):51-6 PMID: 7731498
  13. Effect of galanin on basal and stimulated secretion of prolactin, gonadotropins, thyrotropin, adrenocorticotropin and cortisol in humans.
    Eur J Endocrinol. 1995 Sep;133(3):300-4 PMID: 7581945
  14. Hexarelin, a synthetic growth-hormone releasing peptide, shows no interaction with corticotropin-releasing hormone and vasopressin on adrenocorticotropin and cortisol secretion in humans.
    Neuroendocrinology. 1997 Dec;66(6):432-8 PMID: 9430449
  15. Growth hormone-releasing peptide and its analogues Novel stimuli to growth hormone release.
    Trends Endocrinol Metab. 1995 Mar;6(2):43-9 PMID: 18406682
  16. Galaninergic mechanisms are involved in the regulation of corticotropin and thyrotropin secretion in the rat.
    Endocrinology. 1990 Nov;127(5):2281-9 PMID: 1699744
  17. Evidence for involvement of endogenous somatostatin in the galanin-induced growth hormone secretion in children.
    Pediatr Res. 1990 Apr;27(4 Pt 1):405-7 PMID: 1692988
  18. The growth hormone-releasing activity of hexarelin, a new synthetic hexapeptide, in short normal and obese children and in hypopituitary subjects.
    J Clin Endocrinol Metab. 1995 Feb;80(2):674-8 PMID: 7852535
  19. A receptor in pituitary and hypothalamus that functions in growth hormone release.
    Science. 1996 Aug 16;273(5277):974-7 PMID: 8688086
  20. Binding of a growth hormone releasing hexapeptide to specific hypothalamic and pituitary binding sites.
    Neuropharmacology. 1989 Oct;28(10 ):1139-44 PMID: 2812284
  21. Galanin is a physiological regulator of spontaneous pulsatile secretion of growth hormone in the male rat.
    Endocrinology. 1990 Feb;126(2):1216-22 PMID: 1688791
  22. Growth hormone (GH) release in response to GH-releasing hormone in man is 3-fold enhanced by galanin.
    J Clin Endocrinol Metab. 1987 Dec;65(6):1248-52 PMID: 2445773
  23. Hexarelin, a synthetic growth hormone releasing peptide, stimulates prolactin secretion in acromegalic but not in hyperprolactinaemic patients.
    Clin Endocrinol (Oxf). 1996 Jan;44(1):67-71 PMID: 8706295
  24. Low hexarelin dose and pyridostigmine have additive effect and potentiate to the same extent the GHRH-induced GH response in man.
    Clin Endocrinol (Oxf). 1997 Oct;47(4):495-500 PMID: 9404449
  25. Galanin reinstates the growth hormone response to repeated growth hormone-releasing hormone administration in man.
    Clin Endocrinol (Oxf). 1992 Apr;36(4):347-50 PMID: 1385023
  26. Peptidomimetic regulation of growth hormone secretion.
    Endocr Rev. 1997 Oct;18(5):621-45 PMID: 9331545
  27. Pituitary adenylate cyclase activating polypeptide, growth hormone (GH)-releasing peptide and GH-releasing hormone stimulate GH release through distinct pituitary receptors.
    Endocrinology. 1992 Feb;130(2):939-44 PMID: 1346381
  28. Activation of the hypothalamo-pituitary-adrenal axis by the growth hormone (GH) secretagogue, GH-releasing peptide-6, in rats.
    Endocrinology. 1997 Apr;138(4):1585-91 PMID: 9075719
  29. The effect of an opiate antagonist on the hormonal changes induced by hexarelin.
    Clin Endocrinol (Oxf). 1995 Sep;43(3):365-71 PMID: 7586608
  30. Mediation by the central nervous system is critical to the in vivo activity of the GH secretagogue L-692,585.
    J Endocrinol. 1996 Feb;148(2):371-80 PMID: 8699151
  31. Central effects of growth hormone-releasing hexapeptide (GHRP-6) on growth hormone release are inhibited by central somatostatin action.
    J Endocrinol. 1995 Mar;144(3):555-60 PMID: 7738479
  32. Blocked growth hormone-releasing peptide (GHRP-6)-induced GH secretion and absence of the synergic action of GHRP-6 plus GH-releasing hormone in patients with hypothalamopituitary disconnection: evidence that GHRP-6 main action is exerted at the hypothalamic level.
    J Clin Endocrinol Metab. 1995 Mar;80(3):942-7 PMID: 7883854
  33. Serotonin and the regulation of hypothalamic-pituitary-adrenal axis function.
    Life Sci. 1996;58(20):1683-94 PMID: 8637392
  34. Galanin.
    J Endocrinol Invest. 1991 Oct;14(9):785-94 PMID: 1722230
  35. Growth hormone (GH) secretion in active acromegaly after the combined administration of GH-releasing hormone and GH-releasing peptide-6.
    J Clin Endocrinol Metab. 1994 Aug;79(2):456-60 PMID: 8045963
  36. Acromegaly and Cushing's syndrome due to ectopic production of GHRH and ACTH by a thymic carcinoid tumour: in vitro responses to GHRH and GHRP-6.
    Clin Endocrinol (Oxf). 1998 Feb;48(2):243-50 PMID: 9579239
  37. Interactions of galanin and arginine on growth hormone, prolactin, and insulin secretion in man.
    Metabolism. 1992 Jan;41(1):85-9 PMID: 1371576
  38. Specific receptors for synthetic GH secretagogues in the human brain and pituitary gland.
    J Endocrinol. 1998 Apr;157(1):99-106 PMID: 9614363
  39. Induction of c-fos messenger ribonucleic acid in neuropeptide Y and growth hormone (GH)-releasing factor neurons in the rat arcuate nucleus following systemic injection of the GH secretagogue, GH-releasing peptide-6.
    Endocrinology. 1997 Feb;138(2):771-7 PMID: 9003014
  40. Interaction of the growth hormone releasing peptide hexarelin with somatostatin.
    Clin Endocrinol (Oxf). 1997 Nov;47(5):537-47 PMID: 9425393
  41. Galanin positively modulates prolactin secretion in normal women.
    J Endocrinol Invest. 1996 Dec;19(11):739-44 PMID: 9061507
Article Info
Journal
Journal of endocrinological investigation
Abbr.
J Endocrinol Invest
ISSN
0391-4097
Published
1998-11-00
Pages
673-9
Language
English
Region
Italy
NLM ID
7806594
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com